Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Anne Hedegaard, PhD, Univeristy of Oxford, Oxford, UK, discusses the advantages of using induced pluripotent stem cell (iPSC) models in Alzheimer’s disease research. This interview took place at the Alzheimer’s Research UK Conference 2022 in Brighton, UK.